Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2022 | Challenges of desmoid tumors

Robin Jones • 1 Nov 2022
ESMO 2022
Sarcoma

Robin Jones, MBBS, MRCP, MD, The Royal Marsden NHS Foundation Trust, London, UK, explains desmoid tumors and discusses the main challenges involved in treating them, including their rarity, unpredictability, and the effects on patient quality of life. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Robin Jones

0:58
Challenges in advanced GIST: tackling resistance to therapies
Robin Jones • 4 Jun 2023
0:36
Current treatment landscape for patients with advanced gastrointestinal stromal tumor (GIST)
Robin Jones • 3 Jun 2023
1:13
Updated overall survival findings from the Phase III INTRIGUE trial
Robin Jones • 4 Jun 2023
0:34
INTRIGUE: ripretinib versus sunitinib in GIST
Robin Jones • 4 Jun 2023

Related Videos

0:51
Enhanced NK-cells in stage 4 sarcoma treatment
Vaishali Kumar • 8 Apr 2024
1:12
Predictive biomarkers for checkpoint inhibitors in sarcomas
Nadezhda Omelchenko • 8 Apr 2024
1:26
SAINT and LINNOVATE: combining ICIs and chemotherapy in advanced STC
Nadezhda Omelchenko • 8 Apr 2024
1:47
CCNG1 as a biomarker for DRG-101 gene therapy in cancer
Vaishali Kumar • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals